Title : Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer.

Pub. Date : 2019 Feb

PMID : 30655615






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer. Cyclophosphamide BRCA1 DNA repair associated Homo sapiens